PrEP is highly effective, but many women aren’t included in the conversation. Experts say awareness and access must improve.

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects. Patrick Sullivan, DVM, PhD, an infectious disease ...

Frimpong’s invited commentary discusses the significance of a major efficacy trial involving the game Tumaini and what it ...

During his first term, President Donald Trump set a goal to end the U.S. HIV epidemic by 2030. Now, his administration is reportedly considering cuts to the Centers for Disease Control and ...

The Trump administration is considering drastic funding cuts to federal HIV prevention programs, including possibly eliminating the HIV prevention division at the Centers for Disease Control and ...

The federal government has commenced the rollout of a new long-acting injectable drug (lenacapavir) for the prevention of HIV ...

The Trump administration may be planning to eliminate the Centers for Disease Control and Prevention's Division of HIV Prevention, possibly as soon as this week, news sources reported late Tuesday, ...

“Lenacapavir is a long-acting injectable antiretroviral medication administered once every six months, and provides a ...

The director general of the National Agency for the Control of AIDS,Temitope Ilori,has clarified that the newly introduced ...

Salako revealed that about 52,000 doses of the injectable drug have already been secured to support the initial phase of implementation. The Nigerian government has announced plans to roll out a new ...

Nigeria has begun preparations to roll out Lenacapavir, a long-acting injectable HIV prevention drug, across eight states and ...